• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Baillie Gifford Positive Change Fund B Acc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Baillie Gifford
Fund Summary The Fund aims to produce capital growth over the long term.
SEDOL code BYVGKV5
ISIN GB00BYVGKV59
Fund code BFPCA
Managers Team Managed
Manager Tenure Currently unavailable
Morningstar Category Global Large-Cap Growth Equity
IMA Sector Global
Fund Size Currently unavailable
Fund Type OEIC
Management Style Active
Total Expense Ratio (TER) 0.6%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £1.688
Buy Price £1.688
Price Change -0.3542%
Price Date 21st August 2019
Yield 0.40%
Dividend Frequency Yearly
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 3rd January 2017
Fund Status OPEN

3-year Mean Monthly Return: Currently unavailable

Annual Returns 2018 2017
Fund Performance +4.91% +32.43%
Benchmark Performance
(Global Large-Cap Growth Equity)
-5.22%
Time Period Cumulative Benchmark Performance
(Global Large-Cap Growth Equity)
Fund Compared to Benchmark
1 day 1.07% -0.30% +1.38%
1 week 0.71% +2.78% -2.07%
1 month -2.70% +3.14% -5.84%
3 months 5.02% +6.81% -1.79%
6 months 5.94% +10.47% -4.53%
1 year 0.47% +4.78% -4.31%
3 years Currently unavailable +53.00% Currently unavailable
5 years Currently unavailable +78.87% Currently unavailable
10 years Currently unavailable +201.50% Currently unavailable
YTD 12.33% +16.68% -4.35%
Since inception 69.40% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
Illumina Inc USA 7.18%
Chr. Hansen Holding A/S DNK 5.69%
Taiwan Semiconductor Manufacturing Co Ltd TWN 5.08%
ASML Holding NV KOR 4.90%
M3 Inc JPN 4.81%
Kingspan Group PLC GBR 4.77%
Bank Rakyat Indonesia (Persero) Tbk Class B IDN 4.49%
DexCom Inc USA 4.48%
Novozymes A/S B DNK 4.18%
Abiomed Inc USA 4.17%
Dividend Date Per share amount Reinvestment Price
2nd January 2019 0.0064 £1.5040
2nd January 2018 0.0030 £1.4220